MOHW holds a launching meeting of the pharmaceutical team

Formulation and operation of the strategic planning team for the establishment of the 3rd comprehensive plan for fostering and support

The MOHW (Minister Kwon Deok-cheol) announced at 3 p.m.

 

on the 12th that it will hold a launching meeting of the mid- to long-term strategic planning team for the pharmaceutical industry to establish the "third comprehensive plan for fostering and supporting the pharmaceutical industry." The government shall prepare a five-year comprehensive plan to promote the creation of a foundation for the development of the pharmaceutical industry and strengthening international competitiveness.

 

The comprehensive plan to be established this time is the third plan since the implementation of the system in 2012, and will present a mid- to long-term vision of the pharmaceutical and bio industry promotion policy for the next five years from 2023 to 2027.

 

The MOHW formed a strategic planning team including industry and academic experts (Lee Hyung-hoon, director of health and industry policy at the MOHW, and Lee Byung-gun, chairman of the Korea Sponsor Board of the International Vaccine Research Institute).

 

The strategic planning team will be appointed as a sub-division of each industry (4) and strategy (4) to discuss the basic direction (vision, goal, strategy) of the comprehensive plan and comprehensively review the detailed implementation tasks discussed in each department.

 

At the launching meeting, the results of the second comprehensive plan (2018-2022) were shared, and the strategic planning team and the division's operation plan were discussed.

 

The main achievements of the second comprehensive plan were the expansion of R&D investments by the government and the private sector to promote new drug development, including the Ministry of Health, Science and Technology, Information and Communication, and Trade.

 

To establish the third comprehensive plan, the strategic planning team will hold a meeting at least once a month, and it plans to first operate the industry division in May to June to find tasks for each field, and then prepare detailed action plans in each strategy division.

 

The government plans to operate a strategic planning team (including the division) by the end of this year and announce the third comprehensive plan around December this year after deliberation by the Pharmaceutical Industry Promotion and Support Committee (Chairman, Minister of Health and Welfare).

 

Lee Hyung-hoon, director of the Health and Industry Policy Bureau, said, "The year 2022 when the third comprehensive plan is established is an appropriate time to create a bio-health innovation ecosystem beyond the turning point of COVID-19 and to discuss mid- to long-term directions for Korea to become a pharmaceutical and bio powerhouse." He said, "As this comprehensive plan has been open to various opinions from academia and industry since the beginning of its establishment, industries and research circles will actively participate to express their outlook and opinions, and the planning team will prepare policy tasks and deliberate by the committee."